Ingredia S.A.
11
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Effect of Lactium on Sleep Disorders in Healthy Volunteers With Persistent Subclinical Insomnia
Role: lead
Clinical Study to Assess the Long-term Effect of Pep2Dia® on Glucose Homeostasis in Prediabetic Subjects
Role: lead
Investigation of Milk Peptides (Pep2Dia®) on Postprandial Blood Glucose Profile in Prediabetic Subjects
Role: lead
Postprandial Lipids in IBS and Nutritional Treatment
Role: collaborator
Nutrition to Relieve IBS Constipation
Role: collaborator
Nutrition to Relieve IBS Symptoms by Targeting the Microbiota
Role: collaborator
Postprandial Amino Acid Response After Protein Consumption
Role: collaborator
Nutritional Caracterisation of Micellar Casein
Role: lead
Investigation of Milk Peptides on Postprandial Blood Glucose Profile
Role: lead
Microbiota Profiling in IBS
Role: collaborator
Assessing Associations Between IBS Symptoms, Nutrition and QoL in IBS Patients Using a Questionnaire
Role: collaborator
All 11 trials loaded